The largest database of trusted experimental protocols

13 protocols using cd8 af700

1

SARS-CoV-2 RBD-Specific T-cell Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Approximately 1.5 × 106 cells were stained with antibodies and antibody application was followed by the recommendation. Mouse lymphocytes were stimulated with the peptide pool of SARS-CoV-2 RBD and incubated with monensin [BioLegend (Cat. No. 420701)] for 9 hours. Then, the cells were harvested. For surface staining, cells were stained with fluorescence-labeled mAbs of CD3-FITC (BioLegend, USA), CD4-APC-Cy7 (BioLegend, USA) and CD8-AF700 (BioLegend, USA). The cells were subsequently fixed and permeabilized in permeabilizing buffer (BD Biosciences, USA) and intracellularly stained with fluorescence-labeled mAbs of IFN-γ-BV605 (BioLegend, USA), IL-2-BV421 (BioLegend, USA) and IL-4-PE (BioLegend, USA). All stained cells were detected on BD LSRFortessa™ X-20.
+ Open protocol
+ Expand
2

Multiparameter Flow Cytometry of T-Cell Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells isolated from spleen, lungs or BAL were cultured with 10 µg/ml Purified Protein Derivative of M. tb (PPD-T) (Statens Serum Institut, Copenhagen, DK), 1 µg/ml anti-CD28 (BD Biosciences) and 10 µg/ml Brefeldin A (Sigma-Aldrich) for 16 h at 37 °C/5% CO2. Cells were washed (300 g/5 min) and surface stained for 15 min/4 °C with pre-titrated antibodies: PD-1FITC, CD44-BV785, CD8-AF700, KLRG1-PerCP-Cy5.5, CXCR3-BV421, live/dead-Zombie Aqua (all BioLegend, San Diego, CA, USA), CD90.2-eFluor 450 (eBioscience), and CD4-APC-H7 (BD Biosciences). Cells were then washed, treated with BD Biosciences Cytofix/Cytoperm as per the manufacturer’s instructions and stained intracellularly for 30 min/4 °C with IFN-γ-PE-Cy7, IL-2-APC (both eBioscience) and TNF-α-BV605 (BioLegend). Cells were washed again and acquired using an LSRFortessa™ analyser, utilising a 532 nm laser for PE and PE-conjugate excitation, with FACSDiva™ software (BD Biosciences). Final analysis was performed using FlowJo® software (Tree Star, Ashland, OR, USA) on a minimum of 100,000 live lymphocytes (50,000 for BAL).
+ Open protocol
+ Expand
3

Immune Cell Surface Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
After 3 h stimulation with or without hTRAIL, SVF cells were washed with FACS buffer and stained for membranal antigens (BioLegend, San Diego, CA) anti–CD3-FITC, CD4-BV510, CD8-AF700, and viability dye 780. Then, after 20 min paraformaldehyde fixation, cell were permeabilized and stained with anti–TL1A-PerCP-cy5.5 following the instructions of eBioscience’s FoxP3 intracellular staining kit. Samples were analyzed by a Beckman Coulter CytoFLEX flow cytometer and FlowJo software.
+ Open protocol
+ Expand
4

Detailed Peptide-Stimulated T Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells isolated from spleen, lungs or peripheral blood were cultured with 2 µg/ml of two immunodominant peptides (Pepscan, Lelystad, The Netherlands), [SSTHEANTMAMMARDT] and [AGYAGTLQSLGAEIAV] of the TB10.4 protein, previously demonstrated to stimulate both CD4+ & CD8+ T cell responses (Kaveh & Hogarth, unpublished); 1 µg/ml anti-CD28 (BD Biosciences) and 10 µg/ml Brefeldin A (Sigma) for 16 h at 37 °C/5% CO2. Cells were washed at 300 g for 5 min and surface stained with combinations of CD62L-FITC, CD27-PerCP-Cy5.5, CD8-AF700, CD44-BV421, CD127-PE-Cy7, CD69-FITC, CCR7-BV421, live/dead-Zombie Aqua (all BioLegend) and CD4-APC-H7 (BD Biosciences). Cells were then washed, treated with BD Biosciences Cytofix/Cytoperm as per manufacturer’s instructions and stained intracellularly with combinations of IFN-γ-PE-Cy7, IL-2-APC (both eBioscience), IFN-γ-BV605 and TNF-α-BV605 (both BioLegend). Cells were washed again and analysed using an LSRFortessa™ analyser utilising a 532 nm laser for PE and PE-conjugate excitation with FACSDiva™ software (BD Biosciences). Final analysis was performed using FlowJo® software (Tree Star Inc.) on a minimum of 100,000 live lymphocytes (50,000 for peripheral blood).
+ Open protocol
+ Expand
5

Chemotaxis Assay for Activated CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Supernatants freshly derived from killing assay were immediately adopted for chemotaxis assays. 600 μl of supernatant were placed in the bottom chamber of Corning® Transwell® polycarbonate membrane cell culture inserts 6.5 mm Transwell with 5.0 μm pore polycarbonate membrane insert (CLS3421). CD3-CD28-activated CD8+ T cells were labeled with 2.5 μM of CellTracker Green CMFDA Dye, then resuspended at 1*106 cells/ml in CSTOpTimizer T cell expansion SFM medium (Thermo Fisher, A1048501) without serum. 100 μl of cell suspension was then seeded in the upper chamber of the transwell. After 3 hours of migration, cells migrated to the bottom chamber were collected and stained with CD8 AF700 (BioLegend) and resuspended in 200 μl of PBS. 150 μl of cell suspension was then acquired at constant flow rate (2.5 μl/sec) on a BD 5 laser LSR Fortessa. Data were analyzed using FlowJo V.10. % of migrated cells has been calculated by applying this formula: (Number of cells in the bottom chamber/Number of cells seeded in the upper chamber) x100.
We then calculated the fold change of migration as compared to the untreated conditions (spontaneous migration).
+ Open protocol
+ Expand
6

Lipid Raft Profiling of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs (1 × 106) were stained with fixable blue dead cell stain (ThermoFisher, Waltham, Massachusetts and USA) or Zombie NIR™ Fixable Viability Kit (Biolegend, London, UK). This was followed by washes and surface marker staining with antibodies CD4-BUV395, CD8-AF700, CD19-AF488, and CD14-BV711 (Biolegend, London, UK) followed by subsequent washes. Following surface staining, to determine the expression of membrane lipid rafts cells were subsequently stained with a surrogate lipid raft marker CTB16, conjugated to FITC (1:100 dilution in PBS) (Sigma, Dorset, UK) followed by subsequent washes and fixation in 2% PFA before running on the flow cytometer. Altneratively, cells were fixed filipin complex (Sigma) as described previously [74 (link)]. Stains and washes were carried out in cell staining buffer (Biolegend). Appropriate unstained controls were used for lipid stains.
Data was acquired using a LSRFORTESSA X-20 (BD, Wiltshire, UK) flow cytometer and analysis performed using FlowJo Single Cell Analysis Software (TreeStar). Application settings were created and Cytometer Setup and Tracking (CS&T) (BD) beads were run to assess cytometer performance for each experiment.
+ Open protocol
+ Expand
7

Intracellular Cytokine Staining Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For intracellular staining, brefeldin A was added to the cells and incubated for 4 hours. The cells were placed on ice, harvested, and stained for surface markers for 30 minutes at 4°C in FACS buffer (PBS + 0.5% BSA and 2 mM EDTA). After washing (FACS buffer) the cells were fixed and permeabilized (BD FACS lysing and permeabilization solution 2, BD Biosciences) for 10 minutes. Cells were washed and incubated (30 minutes, 4°C) with antibodies for intracellular staining, washed and acquired using the BD Fortessa X-20 system, and analyzed using FlowJo software (version 10, BD).
The following antibodies were used for flow cytometry: CD16-BV421, CD56-PE-Cy5, CD3-Pacific Blue, CD4-BV786, CD8-AF700, CD161-BV605, and vα7.2-PE-Cy7 from BioLegend; IFN-γ-PE, IP-10-PE, and granzyme B–AF647 from BD Biosciences; and interleukin 15 (IL-15)–APC from Invitrogen.
+ Open protocol
+ Expand
8

Interferon-β Stimulation of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were resuspended in AIM-V media (no FBS/AB serum) and seeded in 24-well ultra-low attachment plates (Corning) at a density of 1 × 106 cells/mL and incubated for 1 hour at 37°C to recover. Next, cells were left unstimulated in AIM-V medium or stimulated with 1000 U/mL of recombinant human IFN-β for 16 hours. Finally, Brefeldin A (1 ug/mL, Sigma) and Monensin (2 µM, Biolegend) were added to the culture media and incubated for an additional 2 hours.
Following incubation, cells were labeled with Zombie Aqua Viability Dye (BioLegend) for 20 minutes at 4°C in the dark, washed with FACS buffer, and stained with a surface antibody cocktail containing CD3-PE/Cy7 (BioLegend, clone UCTH1, 1:400), CD4-APC (BioLegend, clone RPA-T4, 1:100), CD8-AF700 (BioLegend, clone RPA-T8), and CD11c-PE/Dazzle594 (BioLegend, clone Bu15), for 15 minutes at 4°C in the dark. For intracellular staining, the Foxp3 Staining Kit (Thermo Fisher Scientific) was used according to the manufacturer’s instructions. Cells were fixed with Foxp3 Fixation/Permeabilization buffer for 30 minutes at room temperature and then washed with 1× permeabilization buffer. Cells were stained for 45 minutes at room temperature with ISG15-PE (R&D Systems, clone 851701) in 1× permeabilization buffer. Data were acquired on the Symphony A3 flow cytometer (BD, Biosciences) and analyzed using FlowJo v.10.
+ Open protocol
+ Expand
9

Virus-Specific T Cell Functional Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs (1 × 107) were pre-incubated with CellTrace violet (Violet Proliferation Dye 450, BD Biosciences) before generating virus/vaccine restimulated T cell lines. In parallel, 3 × 106 autologous PBMCs were pulsed with MOI4 of UV irradiated H5N2 virus (A/Eurasian Wigeon/MPF4610/07), Vacc A or Vacc C for 90 mins at 37 °C, followed by two PBS wash twice. PBMCs were coupled together and incubated for 4, 10 and 20 days in cRPMI with 10U/mL recombinant IL-2 (Roche) from day 4 onwards, with 50% culture media changes every 2 days. Restimulated PBMCs, and direct ex vivo (day 0) PBMCs were restimulated with MOI4 homologous virus or vaccine on the day of the experiment, plus BFA (BD) at 4 h post stimulation, and incubated for a further 12 h. Cells were stained with anti-human CD3-PETexas, CD4-BV605, CD8-AF700, CCR7-PE and CD45RA-APC (Biolegend). Cells were fixed with Cytofix/cytoperm buffer (BD), and stained for anti-human IFNγ-FITC (Biolegend) in Perm wash buffer (BD). Cells were assessed by flow cytometry on an LSR Fortessa and analysed on FlowJo software. IFN-γ from background controls was subtracted from each sample.
+ Open protocol
+ Expand
10

Multiparametric Immune Profiling of Splenocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenocytes were incubated with either 20 ng mL−1 phorbol myristate acetate (Sigma‐Aldrich) and 1 ug mL−1 ionomycin (Cell Signaling Technology), S protein‐derived peptides (GenScript), N protein‐derived peptides (GenScript), or control (no stimulation) in 1X Brefeldin A and 1X Monensin (Biolegend) solutions for 6 h at 37 °C. Next, the cells were washed with PBS and incubated for 30 min with Fixable Viability Dye eFluor 780 (eBioscience) in PBS (1:1000 dilution) at 4 °C. Cells were then washed once with PBS and twice with PBA before being stained overnight with fluorochrome‐conjugated antibodies (CD3‐FITC (Clone 145‐2C11), CD4‐PerCP‐Cy5.5 (Clone GK1.5), CD8‐AF700 (Clone 53–6.7), CD44‐BV605 (Clone IM7), Biolegend) in PBA at 4 °C. Cells were subsequently washed 3 times with PBA, fixed in 4% PFA, and then permeabilized using a Cyto‐Fast Fix/Perm Buffer Set (Biolegend) according to the manufacturer's protocol. Intracellular staining was performed by incubating the cells with fluorochrome‐conjugated antibodies (IL‐13‐PE (Clone: W17010B), IL‐4‐PE‐Cy7 (Clone: 11B11), IL‐17‐APC (Clone: TC11‐18H10.1), IL‐5‐BV421 (Clone: TRFK5), IFNγ‐BV510 (Clone XMG1.2), Biolegend) in permeabilization buffer for 30 min at 4 °C. Lastly, cells were washed 3 times with permeabilization buffer, resuspended in PBA, and analyzed using the Attune NxT flow cytometer (Thermo Fisher Scientific).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!